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RESEARCH ARTICLE
CD47 differentially regulates white and brown fat function
Heather Norman-Burgdolf1,2,*, Dong Li1,3,*, Patrick Sullivan4,3 and Shuxia Wang1,3,‡
ABSTRACT
Mechanisms that enhance energy expenditure are attractive
therapeutic targets for obesity. Previously we have demonstrated
that mice lacking cd47 are leaner, exhibit increased energy
expenditure, and are protected against diet-induced obesity. In this
study, we further defined the physiological role of cd47 deficiency in
regulating mitochondrial function and energy expenditure in both
white and brown adipose tissue. We observed that cd47 deficient
mice (under normal chow diet) had comparable amount of white fat
mass but reduced white adipocyte size as compared to wild-type
mice. Subsequent ex vivo and in vitro studies suggest enhanced
lipolysis, and not impaired lipogenesis or energy utilization,
contributes to this phenotype. In contrast to white adipose tissue,
there were no obvious morphological differences in brown adipose
tissue between wild-type and knockout mice. However, mitochondria
isolated from brown fat of cd47 deficient mice had significantly higher
rates of free fatty acid-mediated uncoupling. This suggests that
enhanced fuel availability via white adipose tissue lipolysis may
perpetuate elevated brown adipose tissue energy expenditure and
contributes to the lean phenotype observed in cd47 deficient mice.
KEY WORDS: CD47, Brown fat, White fat, Lipolysis, Mitochondria
INTRODUCTION
Over the past thirty years, obesity has become a global health
concern. Obesity is characterized by an excessive accumulation of
body fat. Many obesity-associated comorbidities are a result of
impaired adaptive mechanisms to manage increased lipid burden.
Ideal therapeutic targets for obesity and its associated comorbidities
are mechanisms that enhance lipid catabolism and mitochondrial
function in response to increased lipid burden.
CD47 is a transmembrane cell receptor previously implicated in
self-recognition and immune cell infiltration (Brown and Frazier,
2001; Matozaki et al., 2009; Oldenborg, 2013; Soto-Pantoja et al.,
2015; Soto-Pantoja et al., 2013). CD47 activation negatively
regulates intracellular cyclic guanosine monophosphate (cGMP)
and cGMP-dependent protein kinase (PKG) activity (Isenberg et al.,
2009 a; Isenberg et al., 2006; Ramanathan et al., 2011; Yao et al.,
2011). cGMP/PKG signaling has been previously implicated as a
necessary pathway for healthy adipocyte function and promoter of
energy homeostasis. Downregulation of this specific signaling
cascade has been observed in metabolically-compromised
conditions including obesity, insulin resistance, and fatty liver
disease (Handa et al., 2011; Rizzo et al., 2010; Tateya et al., 2011).
Previously, we identified a novel role of CD47 in a diet-induced
obesity paradigm.We found that cd47 deficiency protected mice from
high fat diet induced obesity, which was attributed to the increased
energy expenditure driven by brown adipose tissue (BAT) activity and
these effects were not compromised under obese conditions
(Maimaitiyiming et al., 2015). These studies further demonstrated
elevated cGMP/PKG levels in BAT of cd47-deficient mice proposing
a potential mechanism for enhanced energy expenditure
(Maimaitiyiming et al., 2015). Interestingly, consistent with a
previous report (Frazier et al., 2011), cd47-deficient mice exhibited
a lean phenotype even under normal chow diet conditions. However,
whether BAT activity drives this lean phenotype is not clear.
The aim of this manuscript is to further elucidate the mechanism
contributing to a lean phenotype in cd47-deficient mice under
physiological conditions. Findings in our current study have
identified novel tissue-specific effects of CD47 on white and
brown adipose tissue. cd47-deficient mice exhibit robust lipid
turnover in white adipose tissue, which may provide a constant
energy source for BAT energy expenditure. Additionally, we
demonstrate that cd47-deficient mice have significant increases in
UCP1 activity in BAT, which contributes to increased energy
expenditure and the lean phenotype.
RESULTS AND DISCUSSION
cd47-deficient white adipose tissue depots contained more
smaller size adipocytes, which was attributed to the
increased lipolysis
CD47 is a transmembrane cell receptor previously implicated in self-
recognition and immune cell infiltration (Brown and Frazier, 2001;
Oldenborg, 2013; Soto-Pantoja et al., 2015). However, previouswork
from our lab and others has shown that global cd47 deficiency results
in a lean phenotype (Fig. S1) and protection from the development of
diet-induced obesity (Frazier et al., 2011; Maimaitiyiming et al.,
2015). To further understand the regulatory role of CD47 on body
composition and energy expenditure, the current studies were
completed to determine what drives the lean phenotype in cd47-
deficient mice under physiological conditions. Particularly, we
examined the physiological role of cd47 deficiency in regulating
mitochondrial function and energy expenditure in both white and
brown adipose tissue. White adipose tissue mass and adipocyte size
was measured in both epididymal adipose tissue (eWAT) and
subcutaneous adipose tissue (sWAT) depots from 8-week-old male
cd47-deficient mice and wild-type (WT) mice. We found that cd47
deficiency was associated with a significant reduction in adipocyte
size (Fig. 1A,D). There was a significant reduction in eWAT mass in
cd47-/-mice as compared toWTmice (Fig. 1B). However, therewere
no significant differences in relative eWAT or sWAT weight to body
weight between WT and cd47-deficient mice (Fig. 1C).Received 17 September 2020; Accepted 19 November 2020
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It has been previously demonstrated that cGMP/PKG signaling
promotes lipolysis by activating lipases critical for the hydrolysis of
triglycerides in lipid droplets (Nikolic et al., 2011; Nishikimi et al.,
2009; Sengen; et al., 2003). In addition, it has been well established
that activation of CD47 [e.g. through its ligand thrombosponidn1
(TSP1)] suppresses cGMP/PKG signaling in a number of tissues
including adipose tissue (Isenberg et al., 2009b; Maimaitiyiming
et al., 2015; Rogers et al., 2014). cGMP signaling has been shown to
be necessary for healthy adipocyte function including adipogenesis,
lipolysis and mitochondria function (Chaves et al., 2011; Haas et al.,
2009; Lafontan et al., 2008; Nikolic et al., 2011; Nishikimi et al.,
2009; Sengenes̀ et al., 2003). Interestingly we found that cGMP
levels were significantly increased in sWAT from cd47−/− mice as
compared to WT mice (Fig. 1E). eWAT had more TSP1 expression
than sWAT (Fig. S2). cd47 deletion significantly reduced TSP1
expression in sWAT but not in eWAT, which suggests that the
differential expression of TSP1 could contribute to the differential
cGMP elevation in sWAT versus eWAT. Consistently, we
demonstrated that lack of CD47 expression enhanced
isoproterenol stimulated glycerol release from both eWAT and
sWAT depots (Fig. 1F). These findings suggest that CD47 is a
potential regulator of the pathway(s) driving lipolysis.
Adipogenesis and mitochondria function was not altered in
cd47 deficient white adipocytes as compared to WT cells
In addition to lipolysis, several other mechanisms such as
lipogenesis/lipid storage and fatty acid oxidation can regulate
intracellular lipid levels within adipocytes (Calderon-Dominguez
et al., 2016). Therefore, to determine whether cd47 deficiency
impairs triglyceride synthesis and storage in white adipocytes,
stromal vascular fractions (SVF) from sWAT of cd47 null or control
mice were isolated and differentiated into white adipocytes. Our
studies demonstrated no significant difference in lipid accumulation
as indicated by Oil Red O staining of intracellular lipid from WT or
cd47 deficient primary white adipocytes (Fig. 2A,B). Consistent
with ex vivo lipolysis data, cd47-deficient white adipocytes had
increased isoproterenol stimulated lipolysis (Fig. 2C). Additionally,
we determined whether there were any alterations of energy
utilization between cd47-deficient cells and control cells.
Mitochondrial respiration was assessed in cd47-deficient and
control primary white adipocytes using the Seahorse XF96 Flux
Analyzer (Agilent Technologies). Basal respiration, ATP
production, and maximal respiratory capacity were determined by
measuring oxygen consumption rates (OCR). cd47-deficient and
control white adipocytes exhibited no significant difference in any
mitochondrial function parameters (Fig. 2D,E). Fatty acid oxidation
(FAO) assay was also performed in white adipocytes using Seahorse
XF96 Flux Analyzer (Agilent Technologies). As shown in Fig. 2F,
FAO capacity was similar between cd47-deficient and control white
adipocytes. From these studies, we saw no differences in lipogenesis
or mitochondrial function between genotypes in vitro. Taken
together, these findings suggest that increased lipolysis might be a
major contributor to the observed smaller adipocyte phenotype from
cd47 deficient white fat deport.
Fig. 1. Morphology and lipolysis of WAT in cd47-deficient mice and WT littermate controls. (A) Representative images of H&E staining in eWAT and
sWAT from cd47-deficient mice and WT littermate controls. Images obtained at 20x magnification. Scale bars: 100 µm. (B) Absolute weights of eWAT and
sWAT and (C) relative eWAT and sWAT weight to body weight ratio are shown. (D) Adipocyte area quantified in eWAT and sWAT using image analysis
software. (E) cGMP levels from eWAT and sWAT were analyzed. Data are presented as mean±s.e. (n=7 mice /group), *P<0.05. (E,F). Basal or 10 µM
isoproterenol stimulated lipolysis of eWAT or sWAT was analyzed by measuring released glycerol in culture media (n=3 mice/group; all tissue samples from
each mouse were triplicated). Two-way ANOVA with post-hoc analysis was used for statistical analysis. *P<0.05; **P<0.01; and ***P<0.001.
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Mitochondria from cd47-deficient BAT exhibited unique
shapes and had enhanced FFA-mediated uncoupling as
compared to wild-type BAT
In the current studies, unique effects were observed in WAT of
cd47-deficient mice compared with WT mice; therefore, BAT
morphology and function was also examined. Unlike WAT,
Hematoxylin and Eosin (H&E) staining exhibited no apparent
morphological changes in BAT of cd47-deficient and WT mice
(Fig. 3A) and no significant differences in BATmass (Fig. 3B,C). In
addition, expression levels of brown adipocyte specific genes such
as UCP1, Cidea and PRDM16 in BAT were comparable between
wild-type and cd47 deficient mice (Fig. 3D). BAT ex vivo lipolysis
rate was also similar between wild-type and cd47-/- mice (Fig. 3E).
These data suggest that CD47 does not affect brown adipocyte
adipogenesis or lipolysis.
In BAT, free fatty acids (FFAs) have multiple physiological
functions. Not only do FFAs serve as an efficient fuel source for
increased energy requirements (Calderon-Dominguez et al.,
2016), but also function as signaling molecules to activate
UCP1 (Fedorenko et al., 2012) and to induce activation of
multiple transcription factors implicated in energy expenditure
(Townsend and Tseng, 2014; Wymann and Schneiter, 2008). Our
lab previously reported that cd47 deficiency may increase fatty
acid translocation into mitochondria by fatty acid transporter
CPT1b and drive the activation of UCP1 and subsequently
increase energy expenditure in BAT (Maimaitiyiming et al.,
2015). Interestingly, in the current study, the electronic
microscope image showed that mitochondria from cd47−/−
BAT had enlarged and elongated shape as compared to WT
mice (Fig. 4A). However, mRNA levels of Drp1 (dynamin-1-like
protein, an important regulator of mitochondria fission) were
comparable betweenWT BAT and cd47−/−BAT (Fig. S3). CD47
has been shown to regulate the cellular localization of Drp1 in
leukemic cells (Bras et al., 2007). Currently, whether there is any
difference of cellular localization changes of Drp1 between WT
BAT and cd47−/− BAT is unknown and warrants further
investigation.
To determine whether the changes of mitochondria shape might
lead to their altered functions (Campello and Scorrano, 2010),
mitochondria were isolated from BAT of cd47-deficient and
littermate control mice and treated with various compounds to
examine mitochondrial bioenergetics, including UCP activity.
Mitochondria isolated from cd47-deficient BAT demonstrated a
significant increase in State IV and FFA-mediated uncoupling when
compared with mitochondria isolated from BAT of WT mice
(Fig. 4C,D). This indicates that cd47-deficient BAT mitochondria
are adapted to consume more oxygen and generate more heat
compared to WT in the presence of FFAs. Analysis of relative
mitochondrial DNA (mtDNA) number indicates that increased
mitochondrial biogenesis is not contributing to the significant
changes in mitochondrial function in cd47 deficient BAT (Fig. 4B).
In this study, we demonstrated that the metabolic function is
regulated in a tissue-specific manner in the absence of CD47. For
example, cd47 deficiency enhances FFA-mediated uncoupling and
Fig. 2. Adipogenesis and mitochondrial function of primary white adipocytes isolated from cd47-deficient and WT mice. (A) Primary white
adipocytes were stained with Oil Red O to determine lipid accumulation on day 8 of differentiation and positive staining was quantified using a microplate
reader. Microscope images were obtained at 20x magnification. Scale bar: 100 µm. (B) Real time PCR was used to determine the expression of AP2 and
adiponectin gene from primary white adipocytes. (C) Basal or isoproterenol stimulated lipolysis in primary white adipocytes. (D) A basic mitochondrial stress
test using the Seahorse XF96 Flux Analyzer was utilized to compare mitochondrial respiration in cd47 deficient and WT primary adipocytes on day 8 of
differentiation. (E) Basal respiration rates, ATP production, and maximal respiratory capacity were presented as pmol/min of oxygen in assay media. All
values were normalized to protein/well. Five to seven replicates were used for each group. (F) Fatty acid oxidation (FAO) was determined by using Seahorse
XF96 Flux Analyzer. Fatty acid β-oxidation was evaluated as maximum percentage of downregulation over baseline OCR after etomoxir injection. Data are
presented as mean±s.e. (n=3 experiments). AA, antimycin A; OCR, oxygen consumption rate; rot, rotenone. **P<0.01.
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energy expenditure in BAT; however, enhanced lipolysis is
observed in WAT. While the studies included in this manuscript
do not define what mechanisms contribute to tissue-specific CD47
function, several factors have been identified that may contribute to
the unique effects of cd47 deficiency in different tissues.
Interestingly, we found that white fat tissue has higher TSP1
mRNA levels than brown fat tissue (Fig. S2). This suggests that the
differences in CD47 function in white and brown adipose tissue
might be secondary to the differential expression of its ligand-TSP1
in these tissues. In addition, CD47 has been shown to undergo post-
transcriptional modifications. Recent studies have demonstrated that
alternative 3′UTRs (untranslated regions) can differentially regulate
CD47 cellular localization and functions (Berkovits and Mayr,
2015). To date, specific CD47 isoform expression in adipose tissue
has not been determined. CD47 may also undergo post-translational
modifications, including glycosylation in a tissue-specific manner
(Brown and Frazier, 2001). Lateral associations and intramembrane
cell receptor complexes including CD47 may differ between cell
types (Kaur et al., 2010). Finally, varying expression levels of CD47
in different tissues as well as the concentration of the specific CD47
ligand/binding partner will determine activity levels and function.
Tissue-specific isoform expression, structural changes, and various
lateral/ligand interactions may suggest unique functional roles of
CD47.
Together, our data suggests that CD47-mediated differential
regulation of white and brown fat function contributes to the
metabolic phenotype observed in the current study. However, to
demonstrate definitively the effect of adipocyte derived CD47 on




Eight-week old male cd47 deficient mice (C57BL6/J background from
Jackson Laboratories) and age-matched WT littermate controls were used
for all studies. Experiments involving mice conformed to the National
Institutes of Health Guide for the Care and Use of Laboratory Animals and
were approved by the University of Kentucky Institutional Animal Care and
Use Committee.
Tissue histology
Adipose tissue depots were embedded in paraffin, sectioned at 4 μm, and
stained with H&E by the University of Kentucky Pathology Core services
from the Center of Research in Obesity and Cardiovascular Disease by
standard procedure. All images were acquired with a Nikon Eclipse 55i
microscope at 20× objective. White adipocyte area was quantified using the
Object Count feature of Nikon NIS Elements BR software (Melville, NY,
USA). Forty adipocytes were measured per section (n=3 sections/mouse)
from mice in each group (n=3 mice/group).
cGMP Measurements
cGMP levels in white fat tissue from wild type or cd47-deficient mice were
measured by using the cGMP Direct Immunoassay Kit (Colorimetric) from
Biovision (Milpitas, CA, USA). Frozen tissues were homogenized and the
supernatant was collected. cGMP levels in the supernatant were measured
and calculated based on the cGMP standard curve following the instruction
manual.
Lipolysis assays
Subcutaneous adipose tissue (SAT), epididymal adipose tissue (EAT), and
BAT were excised from 8-week-old male cd47-deficient and WT littermate
control mice after a 6-h fast. Tissue was weighed and kept in ice cold PBS
until all tissue was collected. Adipose tissue (80–180 mg) was placed in one
Fig. 3. Morphology and lipolysis of BAT in cd47-deficient and WT mice. (A) Representative images of H&E staining in BAT from cd47-deficient mice and
WT littermate controls. Images obtained at 20x magnification. Scale bars: 100 µm. (B) Absolute weight of BAT depots and (C) relative BAT weight to body
weight ratio are shown (n=7/group). (D) Real-time PCR was used to determine the expression of BAT specific genes (e.g. UCP1, Cidea and PRDM16).
(E) Lipolysis of BAT was analyzed. Data are presented as mean±s.e. (n=7 mice /group).
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well of a 24-well plate (n=3 mice/group; all tissue samples from each mouse
were triplicated). Tissues were serum starved in Dulbecco’s Modified Eagle
Medium (DMEM, Gibco, Carlsbad, CA, USA) supplemented with 1% fatty
acid-free bovine serum albumin (BSA) for 1 h at room temperature (RT).
Tissue was then treated with Krebs Ringer Buffer (125 mM NaCl, 5 mM
KCl, 1.8 mMCaCl2, 2.6 mMMgSO4, 5 mMHEPES, pH adjusted to 7.2) in
the presence of vehicle or isoproterenol (10 µM, Sigma-Aldrich, St. Louis,
MO, USA) as previously described (Guo et al., 2013). After 2 h, media was
collected to measure glycerol release with the Free Glycerol Reagent and
appropriate standards (Sigma-Aldrich, St. Louis, MO, USA). Values were
normalized to gram tissue weight (n=3 animals/group and n=3 experimental
replicates/animal).
Adipocyte differentiation
SVF was isolated from subcutaneous WAT as previously described (Gupta
et al., 2010). Briefly, WAT was excised from 8-week-old male cd47-
deficient and WT littermate controls, minced, and digested in Ca2+/Mg2+-
free HBSS supplemented with 0.1% collagenase type II (Catalog No.
C6885, Sigma-Aldrich, St. Louis, MO, USA) for 45 min in a 37°C shaking
water bath. After digestion, cells were centrifuged at 700×g for 10 min at
4°C and the supernatant including the adipocyte layer was removed. The
pellet was digested a second time with collagenase type II digestion buffer.
Cells were then filtered through a 100 μm cell strainer and centrifuged again
at 400×g for 5 min at 4°C. Cells were suspended in culture media
Dulbecco’s Modified Eagle Medium (DMEM, Gibco, Carlsbad, CA, USA)
supplemented with 10% FBS and 1% penicillin-streptomycin. The SVF
was used for differentiation and mitochondrial respiration studies.
Cell differentiation was induced as previously described (Sui et al., 2014)
by high glucose-DMEM supplemented with insulin (1.7 µM), 3-isobutyl-1-
methylxanthine (IBMX; 0.5 mM), dexamethasone (1 µM), and 10%
FBS. After induction, cells were cultured in high glucose-DMEM
supplemented with insulin (1.7 µM) and 10% FBS until day 8 of
differentiation (Sui et al., 2014).
In vitro Oil Red O staining
Mature adipocytes were fixed with 4% paraformaldehyde and subsequently
washed with PBS and freshly prepared 60% isopropanol in water. Cells were
stained with Oil Red O (three volumes of 0.5% Oil Red O in 100%
isopropanol with two volumes distilled water) for 30 min and washed with
water. Images were acquired with a Nikon Edipse 55i microscope. To
quantify lipid accumulation, extracted Oil Red O samples (in 100%
isopropanol) were loaded in triplicate into a microplate and absorbance was
read at 500 nm (Townsend et al., 2013). Absorbance values were
normalized to protein content per well determined by BCA assay and
presented as fold change over control.
Cellular OCR using XF96 extracellular flux analyzer
Adipocyte OCR were measured with the Seahorse Biosciences XF96
Extracellular Flux Analyzer (Agilent Technologies) and used to determine
basic parameters of mitochondrial function including basal respiration,
ATP-linked respiration, and maximal respiratory capacity. Cell density of
mature adipocytes for XF96 plates (Agilent Technologies) were 1×104 cells/
Fig. 4. Morphology and function of mitochondria from BAT in cd47-deficient mice and WT littermate controls. (A) Representative images of
transmission electron microscopy from BAT in cd47-deficient mice and WT littermate controls. Scale bars: 1 µm. L, lipid droplet; M, mitochondria. (B) mtDNA
copy number in BAT was determined by real-time PCR. (C) Mitochondrial respiration (presented as oxygen consumption) was measured using a Clark-type
oxygen electrode under sealed and isothermic conditions. Representative oxygraph traces are presented from isolated BAT mitochondria of cd47-deficient
and WT mice. (D) After the addition of each compound, changes in oxygen consumption are quantified. Data are presented as mean±s.e. (n=4 mice/group),
***P<0.001. mtDNA, mitochondrial DNA; OCR, oxygen consumption rate; PM, pyruvate/malate; ADP, adenosine 5′-diphosphate; FFA, free fatty acid; Oligo,
oligomycin; FCCP, carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone.
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well. Cells were seeded 5 h prior to the assay to ensure adequate adherence
to the plate. Using the protocol provided by Seahorse Biosciences and as
previously described (Zaytseva et al., 2015), cells were treated with three
different compounds and the OCR was measured before and after each
treatment. Experimental compounds were prepared in assay medium
including DMEM media with 10 mM glucose, 1 mM pyruvate and 2 mM
glutamine. First, cells were treated with oligomycin (1 µM), which blunts
ATP synthesis by blocking ATP synthase. Second, cells were treated with
carbonyl cyanide-4-(trifluoromethoxy) phenylhydrazone (FCCP, 2 µM)
which uncouples the electron transport chain and induces high oxygen
consumption and energy expenditure without generating ATP. Finally, cells
were treated with a combination of rotenone (complex I Inhibitor) and
antimycin A (complex III inhibitor) (both 1 µM). This combination inhibits
all mitochondrial respiration and allows the non-mitochondrial respiration
of the cell to be measured. Analysis of data was completed with XFe Wave
Software (Agilent Technologies). All values were normalized to cellular
protein levels which were determined by a modified BCA Assay (Pierce)
based off the manufacturer’s protocol.
FAO test was also determined by using the Seahorse Biosciences XF96
Extracellular Flux Analyzer (Agilent Technologies). Cells were seeded on
Seahorse XF-96 plates at a density of 1×104 cells/well and incubated for 5 h
in culture media. To assess FAO, 1 h prior to the assay, culture media was
replaced with 170 μl of FAO assay media (XF Base DMEM Medium
supplemented with 2 mM glucose and 0.5 mM Carnitine, pH 7.4). During
the assay, 30 μl of 1 mM Palmitate-BSA (XF palmitate–BSA, Agilent
Technology) was added to each well and the final concentration of palmitate
was 0.15 mM. OCR was measured at baseline as well as after sequential
injection of etomoxir (40 μM) and a combination of Rotenone and
antimycin A (1 μM). OCR were expressed as a percentage of the baseline
measurement. Fatty acid β-oxidation was evaluated as maximum percentage
of downregulation over baseline after etomoxir injection.
Assessment of isolated mitochondrial bioenergetics
BATmitochondria were isolated using differential centrifugation with some
modifications to the previously described methods (Sullivan et al., 2003;
Sullivan et al., 2000). Briefly, 500–800 mg adipose tissues were excised,
minced with a blade, and placed in isolation buffer with EGTA (215 mM
mannitol, 75 mM sucrose, 0.1% BSA, 20 mM HEPES, 1 mM EGTA, pH
adjusted to 7.2 with KOH). Tissues were mechanically homogenized at
300 rpm in 4 ml ice cold isolation buffer with EGTA. The homogenate was
centrifuged twice at 1300×g for 3 min in a 2 ml centrifuge tube at 4°C. Each
supernatant fraction was collected in separate tubes and topped off with
isolation buffer with EGTA and finally centrifuged at 13,000×g for 10 min.
The mitochondrial pellet was then suspended in 1 mL isolation buffer
without EGTA and centrifuged for 10 min at 10,000×g. Finally, the
mitochondrial pellet was resuspended in 30–50 µl isolation buffer without
EGTA and stored on ice until the time of assay. The protein concentration
was determined using the BCA assay kit (Pierce, Waltham, MA, USA)
following the manufacturer’s protocol.
Mitochondrial respiration was assessed using a Clark-type oxygen
electrode (Hansatech Instruments), in a sealed, thermostatically controlled
(37°C), and continuously stirred chamber as described previously (Sullivan
et al., 2003; Sullivan et al., 2004).Mitochondriawere added to the chamber to
yield a final protein concentration of 50 µg in 250 µl. State II respiration was
initiated by the addition of oxidative substrates, pyruvate and malate (5 mM
and 2.5 mM, respectively). State III respirationwas initiated by the addition of
120 nmol ADP followed by the addition of oligomycin (1 µM) to induce state
IV respiration. UCP-mediated proton conductance was measured as increased
free fatty acid (60 µM linoleic acid) induced respiration (Sullivan et al., 2003;
Sullivan et al., 2004), followed by recoupling of the mitochondria by
sequestration of FFAwith the addition of BSA to a final concentration of 3%.
Finally, mitochondria were treated with FCCP (1 µM) to allow for
quantification of complex I driven, maximal electron transport.
mtDNA copy number
mtDNA copy number in BAT was determined as previously described
(Maimaitiyiming et al., 2015). The relative copy number was determined by
real-time PCR and normalized to nuclear DNA (28 s). Primer sequences for
mouse mtDNA were forward: 5′-CCG-CAA-GGG-AAA-GAT-GAA-
AGA-C-3′ and reverse: 5′-TCG-TTT-GGT-TTC-GGG-GTT-TC-3′.
Sequences for mouse 28 s were forward: 5′-GCC-AGC-CTC-TCC-TGA-
TTT-TAG-TGT-3′ and reverse: 5′-GGG-AAC-ACA-AAA-GAC-CTC-
TTC-TGG-3′.
Real-time quantitative PCR
Total RNA from frozen BAT or cells was extracted using RNeasy Mini Kit
(Qiagen, USA). RNA was reverse transcribed to cDNA by High Capacity
cDNA Reverse Transcription Kit (Invitrogen, Carlsband, CA, USA). Real-
time quantitative PCR was performed on a MyiQ Real-time PCR Thermal
Cycler (Bio-Rad) with SYBR Green PCR Master Kit (Qiagen, Valencia,
CA, USA). Relative mRNA expression was calculated using the MyiQ
system software as previous reported (Li et al., 2011) and normalized to
β-actin mRNA levels. All primer sequences utilized in this study are listed as
below: AP2: forward AAGCCCACTCCCACTTCTTT, reverse TCACCT-
GGAAGACAGCTCCT; Adiponectin: forward AACATTCCGGGACTC-
TAC T, reverse TACTGGTCGTAGGTGAAGAG; UCP1: forward (5′ to 3′)
ACTGCCACACCTCCAGTCATT, reverse (5′ to 3′) CTTTGCCTCACT-
CAGGATTGG; Cidea: forward AGGGACAACACGCATTTC, reverse G-
TAGGACACCGAGTACATCT; PRDM16: forward CACAAGACATC-
TGAGGACAC, reverse CTCGTGTTCGTGCTTCTT; TSP1: forward T-
GTGGAAACAAGTCACCCAGTCCT, reverse TTTCCTGTGTGCCAC-
AGTGCATTC; Drp1: forward ACCGGGAATGACCAAAGTACCTGT,
reverse ACGGCGAGGATAATGGAATTGGGA.
Transmission electron microscopy
For ultrastructural analysis of mitochondria, fragments of the BAT obtained
from WT and cd47-deficient mice were dissected and fixed with 2.5%
glutaraldehyde in cacodilate buffer 0.1 M (pH 7.2). The samples were
shipped to August University Electron Microscopy Core Facility for further
processing and imaging.
Statistical analysis
Statistical analysis was performed using Prism version 8.0.2 (GraphPad
Software, San Diego, CA, USA). Data are expressed as mean values±s.e.
Statistical significance between two groups was determined using two-tailed
Student’s t-test. One-way ANOVA followed by Bonferroni’s multiple
comparisons test or two-way ANOVA followed by Tukey’s multiple
comparisons test was applied for multi-group comparisons. P-values of less
than 0.05 were considered to be significant.
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Fig. S1. Body weight (A), body composition determined by EchoMRI including fat 
mass and lean mass (B) and percent of fat mass and lean mass to body weight (C), 
and daily food consumption (D)  from male WT and cd47 deficient mice under normal 
chow diet. Data are represented as mean ± SE (N=7 mice/group). *P<0.05 vs. WT; 
**P<0.01 vs. WT.  


















































Fig. S2. Expression of TSP1 in different fat depots from WT or cd47 deficient mice was 
determined by real-time PCR and normalized to β-actin levels.  Data are represented as mean ±
SE (N=7 mice/group). *P<0.05; **P<0.01.  















































Fig. S3. Expression of DRP1 in BAT from WT or cd47 deficient mice was determined by real-time 
PCR and normalized to β-actin levels.  Data are represented as mean ± SE (N=7 mice/group). 
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